Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Robbins

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chaos (Woodbury, N.Y.)|January 1, 1992
Winding number formula for Maslov indicesJonathan Robbins
Biochemical and Biophysical Research Communications|November 1, 2003
Identification of a carcinoembryonic antigen binding protein on monocytesAniruddha Ganguly, Ersan Yeltsin, Jonathan Robbins
The Journal of the American Academy of Orthopaedic Surgeons|February 19, 2026
Letter to the Editor: Opioid Use Disorder and Perioperative Pain Management-The Practice of Discontinuing Buprenorphine Perioperatively Does Not Align With Expert ConsensusKerith Hartmann, Jonathan Robbins, Madison Hayes-Lattin, et al.
Medical Education Online|November 5, 2022
Preparing fourth year medical students to care for patients with opioid use disorder: how this training affects their intention to seek addiction care opportunities during residencyKatharine F Marshall, Patricia A Carney, Kathryn J Bonuck, et al.
Journal of Addiction Medicine|May 18, 2021
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort AnalysisDana Button, Jennifer Hartley, Jonathan Robbins, et al.
Thrombosis and Haemostasis|November 13, 2002
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparinDaichi Shimbo, Julio Osende, Julie Chen, et al.
Journal of Substance Abuse Treatment|June 24, 2019
Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veteransKevin L Kraemer, Kathleen A McGinnis, David A Fiellin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human studyEli I Lev, Jonathan D Marmur, Milan Zdravkovic, et al.
Substance Use & Addiction Journal|June 22, 2024
Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled TrialMelessa Salay, Karlyn A Edwards, Erin L Winstanley, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chaos (Woodbury, N.Y.)|January 1, 1992
Winding number formula for Maslov indicesJonathan Robbins
Biochemical and Biophysical Research Communications|November 1, 2003
Identification of a carcinoembryonic antigen binding protein on monocytesAniruddha Ganguly, Ersan Yeltsin, Jonathan Robbins
The Journal of the American Academy of Orthopaedic Surgeons|February 19, 2026
Letter to the Editor: Opioid Use Disorder and Perioperative Pain Management-The Practice of Discontinuing Buprenorphine Perioperatively Does Not Align With Expert ConsensusKerith Hartmann, Jonathan Robbins, Madison Hayes-Lattin, et al.
Medical Education Online|November 5, 2022
Preparing fourth year medical students to care for patients with opioid use disorder: how this training affects their intention to seek addiction care opportunities during residencyKatharine F Marshall, Patricia A Carney, Kathryn J Bonuck, et al.
Journal of Addiction Medicine|May 18, 2021
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort AnalysisDana Button, Jennifer Hartley, Jonathan Robbins, et al.
Thrombosis and Haemostasis|November 13, 2002
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparinDaichi Shimbo, Julio Osende, Julie Chen, et al.
Journal of Substance Abuse Treatment|June 24, 2019
Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veteransKevin L Kraemer, Kathleen A McGinnis, David A Fiellin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human studyEli I Lev, Jonathan D Marmur, Milan Zdravkovic, et al.
Substance Use & Addiction Journal|June 22, 2024
Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled TrialMelessa Salay, Karlyn A Edwards, Erin L Winstanley, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
Pageof 1